French Biotech XENOTHERA Publishes Its Results at The World Cancer Congress in Chicago (ASCO)
XENOTHERA announces its participation in the American Society of Clinical Oncology (ASCO) congress, where the world's cancer experts gather each year to share the latest clinical trial data and innovations